Biogen, Eisai Get FDA Nod for Leqembi IV Maintenance Dosing
Biogen and Eisai have won Food and Drug Administration approval of an intravenous maintenance dosing of their Leqembi drug for early Alzheimer's disease. The companies late Sunday said the FDA approved the maintenance dosing of once every four weeks after 18 months of the initiation phase of once every two weeks.
1don MSN
The U.S. Food and Drug Administration wants to put nutrition information front and center on food products to give consumers ...
The U.S. Food and Drug Administration has pulled draft guidance from its website requiring companies to test medicines and ...
An injectable blood pressure drug has been recalled after the FDA has warned it could cause side effects, such as stroke or death.
Over 35 years after the first study linking the artificial food dye Red 3 to thyroid cancer in rats was published, the U.S.
In 2024, food recalls in the US seemed to soar. Between headline-making outbreaks of listeria and E. coli and problems with ...
The FDA announced the changes in a “ prevention strategy ” to keep fresh and frozen berries from being contaminated with ...
The Food and Drug Administration released on Tuesday its long-awaited proposal to require food manufacturers to put some nutrition facts on the front of packages, in a bid to nudge Americans and ...
The Trump administration has put a freeze on many federal health agency communications with the public through at least the ...
Dr. Dorothy Fink, the acting secretary for the Department of Health and Human Services under President Donald Trump, has ...
Robert F. Kennedy Jr. has said vaccines are not safe. His support for abortion access has made conservatives uncomfortable.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback